-
公开(公告)号:JPH10175929A
公开(公告)日:1998-06-30
申请号:JP32491397
申请日:1997-11-26
Applicant: BASF AG
Inventor: SCHOENHERR MICHAEL DR , RAULS MATTHIAS DR , ASCHERL HERMANN , LETZELTER THOMAS , BAUMANN DIETER , POTTHOFF-KARL BIRGIT DR
IPC: C11D1/04 , C07C227/42 , C07C229/16 , C07C229/24
Abstract: PROBLEM TO BE SOLVED: To obtain a crystalline solid of the subject compound substantially not containing an additive and having virtually sufficiently low hygroscopic property. SOLUTION: This crystalline solid constituted of a glycine-N,N-diacetic acid derivative represented by formula I [R is a 1-30C alkyl or a 2-30C alkenyl, a group of formula II (A is a 1-12C alkylene bridge, etc.; M is H or an alkali metal, etc.), etc.] is produced by distilling away water content of an aqueous solution of (A) glycine-N,N-diacetic acid derivative I [R is a 1-20C alkyl or a group of formula II, etc.] as a starting substance. Crystallization is carried out by adding a crystalline component A in an amount of 0.001-50wt.%, preferably 0.01-10wt.% based on an amount of the component A in a starting substance as a nucleus for crystallization and the crystallization temperature is controlled to 10-100 deg.C, especially 40-80 deg.C. The resultant crystalline solid has a purity of 70-99.9%, especially 80-99.5% based on total amount of solid.
-
公开(公告)号:DE4301543A1
公开(公告)日:1994-07-14
申请号:DE4301543
申请日:1993-01-21
Applicant: BASF AG
Inventor: SCHOENHERR MICHAEL DR , AHLERS JUERGEN , BUCHERT HERMANN DR
IPC: C08J3/12 , C08L71/10 , C09D5/46 , C09D171/10 , C08L81/06 , C08J3/05 , C09D181/06 , C09D5/02
-
公开(公告)号:DE50111767D1
公开(公告)日:2007-02-15
申请号:DE50111767
申请日:2001-03-06
Applicant: BASF AG
Inventor: KOLTER KARL DR , SCHOENHERR MICHAEL DR , ASCHERL HERMANN
IPC: A61K9/22 , A61K47/32 , A61K9/16 , A61K9/20 , A61K9/28 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/24 , A61K47/34 , A61K47/38 , A61P3/02
Abstract: The present invention relates to oral dosage forms with delayed release of active ingredient and high mechanical stability, comprising a) one or more active ingredients b) a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone c) water-soluble polymers or low or high molecular weight lipophilic additives d) and other conventional excipients, and to the use and production thereof.
-
公开(公告)号:AT350018T
公开(公告)日:2007-01-15
申请号:AT01105547
申请日:2001-03-06
Applicant: BASF AG
Inventor: KOLTER KARL DR , SCHOENHERR MICHAEL DR , ASCHERL HERMANN
IPC: A61K47/32 , A61K9/16 , A61K9/20 , A61K9/22 , A61K9/28 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/24 , A61K47/34 , A61K47/38 , A61P3/02
Abstract: The present invention relates to oral dosage forms with delayed release of active ingredient and high mechanical stability, comprising a) one or more active ingredients b) a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone c) water-soluble polymers or low or high molecular weight lipophilic additives d) and other conventional excipients, and to the use and production thereof.
-
公开(公告)号:AT324870T
公开(公告)日:2006-06-15
申请号:AT01105545
申请日:2001-03-06
Applicant: BASF AG
Inventor: KOLTER KARL DR , SCHOENHERR MICHAEL DR , ASCHERL HERMANN
IPC: A61K9/00 , A61K9/20 , A61K9/22 , A61K9/52 , A61K31/5513 , A61K45/00 , A61K47/10 , A61K47/12 , A61K47/32 , A61K47/36 , A61K47/38
Abstract: Sustained-release oral dosage form that floats in gastric fluid comprises: (1) one or more active ingredients; (2) a blend of polyvinyl acetate (PVAc) and polyvinylpyrrolidone (PVP); and optionally (3) excipients. An independent claim is also included for production of the dosage form by compression at a pressure below 100 MPa.
-
公开(公告)号:AT202075T
公开(公告)日:2001-06-15
申请号:AT97119147
申请日:1997-11-03
Applicant: BASF AG
Inventor: SCHOENHERR MICHAEL DR , RAULS MATTHIAS DR , ASCHERL HERMANN , LETZELTER THOMAS , BAUMANN DIETER , POTTHOFF-KARL BIRGIT DR
IPC: C11D1/04 , C07C227/42 , C07C229/16 , C07C229/24
Abstract: A method for the preparation of a crystalline solid comprising a glycine-N,N-diacetic acid derivative of formula (I) with a very low hygroscopicity, comprises fixing the water content of the starting material containing (I) at 10-30 wt.% and then carrying out crystallisation: MOOC-CH(R)-N(CH2COOM)2 (I) R = 1-30C alkyl or 2-30C alkenyl (both optionally containing 1-5 OH, formyl, 1-4C alkoxy(carbonyl) or phenoxy groups and/or optionally containing up to 5 non-adjacent O atoms in the chain), alkoxylate groups of formula (II), phenyl-(1-20 C)-alkyl (optionally containing up to 3 1-4C alkyl, OH, carboxyl, sulpho or 1-4C alkoxycarbonyl ring substituents), 5- or 6-membered optionally benzalated heterocyclic ring containing up to 3 N, O or S atoms (optionally containing up to 3 1-4C alkyl, OH, carboxyl, sulpho or 1-4C alkoxycarbonyl substituents) or a group of formula (III): -(CH2)k-O-(A O)m-(A O)n-Y (II) -A-CH(COOM)-N(CH2COOM)2 (III) A , A = 2-4C 1,2-alkylene; Y = H, 1-12C alkyl, phenyl or 1-4C alkoxycarbonyl; k = 1-3; m, n = 0-50; A = 1-12C alkylene or single bond; and M = H, alkali(ne earth) metal or optionally substituted ammonium, with the provision that m+n = at least 4.
-
公开(公告)号:DE19507522A1
公开(公告)日:1996-09-05
申请号:DE19507522
申请日:1995-03-03
Applicant: BASF AG
Inventor: WEHLAGE THOMAS DR , KAPPES ELISABETH DR , OFTRING ALFRED DR , SCHOENHERR MICHAEL DR , BECKER RAINER DR
IPC: C07D217/02 , C07D217/04
Abstract: Prodn. of 3,4-dihydro-isoquinoline cpds. of formula (I) comprises oxidising 1,2,3,4-tetrahydro-isoquinoline cpds. of formula (II) with NaOCl and/or KOCl in the absence of organic solvents. R2, R3 = R' or R"; R' = 1-20C alkyl, up to 20C cycloalkyl or aryl (all opt. substd. by aryl, NO2, CN, halogen, 1-20C alkyl, amino, 1-20 aminoalkyl, 1-20C thioalkyl, 1-20 sulphoalkyl, carboxylate ester, OH, 1-20C alkoxy, polyalkoxy or 1-40C quaternised di- or tri- alkylammonium or carboxyalkyl), H or heterocyclyl; R" = NO2, halo, CN, 1-20C alkoxy, phenoxy, benzyloxy, keto, COOH, 1-20C carboalkoxy, NH2 or mono- or di(1-6C alkyl)amino. Also claimed is a process as above where the prod. is quaternised with R1X to give a 3,4-dihydro-isoquinolinium salt of formula (III). R1 = R'; X = oxidn.-stable anion, pref. Cl, Br, sulphate, methylsulphate, sulphonate, p-toluenesulphonate, boron tetrafluoride, phosphorus pentafluoride, phosphate, cyanide or ethylsulphate.
-
公开(公告)号:DE50109662D1
公开(公告)日:2006-06-08
申请号:DE50109662
申请日:2001-03-06
Applicant: BASF AG
Inventor: KOLTER KARL DR , SCHOENHERR MICHAEL DR , ASCHERL HERMANN
IPC: A61K9/22 , A61K9/00 , A61K9/20 , A61K9/52 , A61K31/5513 , A61K45/00 , A61K47/10 , A61K47/12 , A61K47/32 , A61K47/36 , A61K47/38
Abstract: Sustained-release oral dosage form that floats in gastric fluid comprises: (1) one or more active ingredients; (2) a blend of polyvinyl acetate (PVAc) and polyvinylpyrrolidone (PVP); and optionally (3) excipients. An independent claim is also included for production of the dosage form by compression at a pressure below 100 MPa.
-
公开(公告)号:DE19649681A1
公开(公告)日:1998-06-04
申请号:DE19649681
申请日:1996-11-29
Applicant: BASF AG
Inventor: SCHOENHERR MICHAEL DR , RAULS MATTHIAS DR , ASCHERL HERMANN , LETZELTER THOMAS , BAUMANN DIETER , POTTHOFF-KARL BIRGIT DR
IPC: C11D1/04 , C07C227/42 , C07C229/16 , C07C229/24 , C07C229/22 , C11D3/33
Abstract: A method for the preparation of a crystalline solid comprising a glycine-N,N-diacetic acid derivative of formula (I) with a very low hygroscopicity, comprises fixing the water content of the starting material containing (I) at 10-30 wt.% and then carrying out crystallisation: MOOC-CH(R)-N(CH2COOM)2 (I) R = 1-30C alkyl or 2-30C alkenyl (both optionally containing 1-5 OH, formyl, 1-4C alkoxy(carbonyl) or phenoxy groups and/or optionally containing up to 5 non-adjacent O atoms in the chain), alkoxylate groups of formula (II), phenyl-(1-20 C)-alkyl (optionally containing up to 3 1-4C alkyl, OH, carboxyl, sulpho or 1-4C alkoxycarbonyl ring substituents), 5- or 6-membered optionally benzalated heterocyclic ring containing up to 3 N, O or S atoms (optionally containing up to 3 1-4C alkyl, OH, carboxyl, sulpho or 1-4C alkoxycarbonyl substituents) or a group of formula (III): -(CH2)k-O-(A O)m-(A O)n-Y (II) -A-CH(COOM)-N(CH2COOM)2 (III) A , A = 2-4C 1,2-alkylene; Y = H, 1-12C alkyl, phenyl or 1-4C alkoxycarbonyl; k = 1-3; m, n = 0-50; A = 1-12C alkylene or single bond; and M = H, alkali(ne earth) metal or optionally substituted ammonium, with the provision that m+n = at least 4.
-
公开(公告)号:DE19649384A1
公开(公告)日:1998-06-04
申请号:DE19649384
申请日:1996-11-29
Applicant: BASF AG
Inventor: BOECKH DIETER DR , SCHUERMANN GREGOR DR , MUNDINGER KLAUS DR , SCHOENHERR MICHAEL DR
IPC: C11D1/02 , C11D1/66 , C11D1/83 , C11D3/12 , C11D3/28 , C11D3/30 , C11D3/37 , C11D17/06 , C11D3/39 , C11D3/395 , C11D3/08 , C11D3/065 , D06L1/12
Abstract: Textile detergent formulation containing a) 0.1 - 10 wt % quaternized glycine nitriles, b) 0.5-40 wt % bleaching agents in the form of peroxo compounds and/or peracids, c) 0.5 - 50 wt % non-ionic and/or anionic tensides and d) 5-85 wt % calcium ion and/or magnesium ion sequestering compounds. The formulation is suitable for household and industrial textile washing, in a dosage of over 2g per litre detergent solution, in particular in a textile: detergent solution bath ratio of 1:10 to 1:2.
-
-
-
-
-
-
-
-
-